TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Helga D Munch-Petersen, Fazila Asmar, Konstantinos Dimopoulos, Aušrinė Areškevičiūtė, Peter Brown, Mia Seremet Girkov, Anja Pedersen, Lene D Sjö, Steffen Heegaard, Helle Broholm, Lasse S Kristensen, Elisabeth Ralfkiaer, Kirsten Grønbæk
Dive into the research topics of 'TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy'. Together they form a unique fingerprint.